Beacon Angels Meeting Tuesday,May 14, 2024

We shall entertain new funding presentations as follows:

• 8:30 - 9:00 AM, Relavo, A novel connection device that reduces the risk of infection in Peritoneal dialysis (PD), a home-based treatment for kidney failure.
• 9:15- 9:45 AM, DeepLook Medical, FDA approved shape-recognition software to improve cancer screening, diagnosis and treatment.

Beacon portfolio updates:

• 10:00 - 10:20 AM, TBD

Members shall report on pending funding rounds, by Series number.

• 112B Theromics developing tumor-targeting therapies;
• 116B Realplay providing video highlights for youth sports
• 122 GelMedix improving drug delivery for the eye; and
• 126 myBiometry developing an advanced early-warning system for asthma attacks.
• 127 Agile Devices a novel microcatheter with a deflectble tip for challenging anatomy

Members will report on companies now in due diligence:

• AI Lean (Dave Smith)
• AGED Diagnostics (Kevin Richard)